BREAKTHROUGH T1D
LIVE

Serial Number

98527916

Owner

BREAKTHROUGH T1D

Attorney

Emily R. Billig

First Use Date

Jun 30, 2024

Filing Date

Apr 30, 2024

Add to watchlist:

No watchlists yet
View on USPTO

BREAKTHROUGH T1D Trademark

Serial Number: 98527916 • Registration: 8286310

BREAKTHROUGH T1D is a trademark filed by BREAKTHROUGH T1D on April 30, 2024. The trademark is classified under Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

BREAKTHROUGH T1D (43 trademarks)

200 VESEY STREET, 28TH FLOOR
NEW YORK, NY 10281

Entity Type: 54

JDRF International

New York, NY 10281

Entity Type: 03

Trademark Details

Filing Date

April 30, 2024

Registration Date

June 2, 2026

First Use Anywhere

June 30, 2024

First Use in Commerce

June 30, 2024

Published for Opposition

April 1, 2025

Goods & Services

Providing information in the field of prevention, screening, diagnosis and treatment of type 1 diabetes; providing information in the field of prevention, screening, diagnosis and treatment of type 1 diabetes via a website; providing health information; providing health information in the field of type 1 diabetes; Providing an online searchable database featuring medical information regarding type 1 diabetes

Charitable fundraising; online charitable fundraising; charitable fundraising services by means of organizing and conducting special events; charitable fundraising services by means of running and walking events; charitable fundraising services for promoting research and education relating to type 1 diabetes; charitable foundation services, namely, providing fundraising activities and investment management services to support type 1 diabetes research

Association services, namely, promoting the public interest and awareness of curing, treating, and preventing type 1 diabetes; promoting public awareness of type 1 diabetes, type 1 diabetes research, and treatments, preventions and cures for type 1 diabetes, by means of public advocacy

Providing information about medical research; providing information about medical research in the field of type 1 diabetes; Providing information about medical and scientific research via a website; Providing medical and scientific research information in the field of clinical trials; Providing an online searchable database in the field of scientific research on type 1 diabetes, for scientific research purposes

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 2, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 2, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 14, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 14, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Apr 21, 2026 SUPC
USE AMENDMENT FILED
Nov 26, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Nov 26, 2025 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 27, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 1, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 1, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 26, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 10, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 10, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 10, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 10, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 8, 2024 GNRN
NON-FINAL ACTION E-MAILED
Nov 8, 2024 GNRT
NON-FINAL ACTION WRITTEN
Nov 8, 2024 CNRT
ASSIGNED TO EXAMINER
Nov 8, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Oct 27, 2024 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 27, 2024 NWOS
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 8, 2024 ASGN
NEW APPLICATION ENTERED
Apr 30, 2024 NWAP